Browse Pet Safety Reports
1,329,678 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 1,329,678 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product — widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 1,329,678 FDA veterinary adverse event reports.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Oct 4, 2025 | Dog | Deutsche Dogge, Great Dane,... | Sarolaner | Blood in vomit; Bloody diarrhoea; Anorexia; Leucopenia NOS; Eosinopenia; Hypo... | Ongoing |
| Oct 4, 2025 | Dog | Coonhound (unspecified) | Pyrantel Pamoate;Sarolaner | Lack of efficacy (endoparasite) - tapeworm | Ongoing |
| Oct 4, 2025 | Dog | Chihuahua | Selamectin | Lack of efficacy (ectoparasite) - tick NOS | Outcome Unknown |
| Oct 4, 2025 | Cat | Domestic Shorthair | Velagliflozin Proline Monohydrate | Diarrhoea; Weight loss; Ketosis; Lack of efficacy - NOS | Outcome Unknown |
| Oct 4, 2025 | Dog | Chihuahua, Dog (unknown) | Maropitant Citrate | Emesis (multiple); Lethargy (see also Central nervous system depression in Ne... | Recovered/Normal |
| Oct 4, 2025 | Dog | Shepherd Dog - Australian | Maropitant Citrate | Hind limb paralysis; Other abnormal test result NOS; Intentional misuse | Outcome Unknown |
| Oct 4, 2025 | Dog | Boxer (German Boxer), Cross... | Lotilaner,Moxidectin,Praziquantel,Pyr... | Behavioural disorder NOS; Decreased appetite; Lethargy (see also Central nerv... | Ongoing |
| Oct 4, 2025 | Cat | Domestic Shorthair | Cefovecin | Elevated symmetrical dimethylarginine (SDMA); Elevated blood urea nitrogen (B... | Ongoing |
| Oct 4, 2025 | Dog | Crossbred Canine/dog | Fluralaner 13.64% 12-Week Chew | Lack of efficacy (ectoparasite) - tick NOS | Ongoing |
| Oct 4, 2025 | Dog | Crossbred Canine/dog | Afoxolaner 37.5Mg / Moxidectin 180Mcg... | Lack of efficacy (endoparasite) - tapeworm | Outcome Unknown |
| Oct 4, 2025 | Dog | Pit Bull, Dog (unknown) | Tigilanol Tiglate | Swollen limb; Skin warmth; Localised oedema (not application site); Lack of e... | Outcome Unknown |
| Oct 4, 2025 | Dog | Hound (unspecified), Dog (u... | Pyrantel Pamoate;Sarolaner | Lack of efficacy (endoparasite) - heartworm | Ongoing |
| Oct 4, 2025 | Dog | Crossbred Canine/dog | Selamectin | Lack of efficacy (endoparasite) - heartworm | Outcome Unknown |
| Oct 4, 2025 | Dog | Retriever - Labrador | Lotilaner | Lack of efficacy (bacteria) - Anaplasma; Lack of efficacy (bacteria) - NOS | Outcome Unknown |
| Oct 4, 2025 | Dog | Retriever - Labrador | Bedinvetmab | Polyuria; Polydipsia | Ongoing |
| Oct 3, 2025 | Cat | Domestic Shorthair | Bexagliflozin | Other abnormal test result NOS | Ongoing |
| Oct 3, 2025 | Dog | Crossbred Canine/dog | Pyrantel Pamoate;Sarolaner | Drooling; Emesis (multiple); Diarrhoea; Polydipsia | Recovered/Normal |
| Oct 3, 2025 | Cat | Domestic Shorthair | Eprinomectin; Praziquantel | Drooling; Hyperactivity | Recovered/Normal |
| Oct 3, 2025 | Cat | Cat (other) | Sarolaner | Emesis; Diarrhoea; Not eating; Medication error NOS | Ongoing |
| Oct 3, 2025 | Dog | Crossbred Canine/dog | Milbemycin Oxime; Praziquantel | Lack of efficacy (endoparasite) - heartworm | Outcome Unknown |
| Oct 3, 2025 | Dog | Siberian Husky, Dog (unknown) | Bedinvetmab | Proprioception deficit; Ataxia; Limb non-weight bearing; Cough; Musculoskelet... | Euthanized |
| Oct 3, 2025 | Dog | Foxhound (unspecified) | Pyrantel Pamoate;Sarolaner | Lack of efficacy (endoparasite) - hookworm | Ongoing |
| Oct 3, 2025 | Dog | Pug | Fluralaner 13.64% 12-Week Chew | Hyperactivity; Lethargy (see also Central nervous system depression in Neurol... | Ongoing |
| Oct 3, 2025 | Dog | Retriever - Golden | Fluralaner 13.64% 12-Week Chew | Vomiting | Recovered/Normal |
| Oct 3, 2025 | Dog | Poodle (unspecified), Dog (... | Pyrantel Pamoate;Sarolaner | Decreased appetite; Product defect, product difficult to use/handle (see also... | Outcome Unknown |
| Oct 3, 2025 | Dog | Spitz - German Pomeranian | Afoxolaner 18.75Mg / Moxidectin 90Mcg... | Seizure NOS; Paddling; Foaming at the mouth; Biting -aggression (see also Ski... | Recovered/Normal |
| Oct 3, 2025 | Dog | Hound (unspecified) | Afoxolaner 75Mg / Moxidectin 360Mcg /... | Hair loss NOS; Itching; Reddening of the skin; Hives (see also Skin); Hyperse... | Recovered/Normal |
| Oct 3, 2025 | Cat | Domestic Shorthair | Selamectin;Sarolaner | Disorientation; Stumbling gait; Itching | Recovered/Normal |
| Oct 3, 2025 | Cat | Cat (unknown) | Pregabalin | Lack of efficacy - NOS | Outcome Unknown |
| Oct 3, 2025 | Dog | Hound (unspecified), Dog (u... | Lotilaner,Moxidectin,Praziquantel,Pyr... | Lack of efficacy (endoparasite) - heartworm | Outcome Unknown |
| Oct 3, 2025 | Dog | Dog (unknown) | Milbemycin Oxime; Praziquantel | Weight loss | Outcome Unknown |
| Oct 3, 2025 | Cattle | Red Angus, Cattle (unknown) | Doramectin | Lack of efficacy (endoparasite) - Trichostrongylus | Outcome Unknown |
| Oct 3, 2025 | Cat | Domestic Mediumhair | Velagliflozin Proline Monohydrate | Loose stool; Polyuria; Polydipsia | Recovered/Normal |
| Oct 3, 2025 | Dog | Shepherd Dog - Australian | Pyrantel Pamoate;Sarolaner | Lack of efficacy (bacteria) - Borrelia; Lack of efficacy (bacteria) - Anaplas... | Ongoing |
| Oct 3, 2025 | Horse | Horse (unknown) | Praziquantel;Moxidectin | Hives (see also Skin) | Outcome Unknown |
| Oct 3, 2025 | Dog | Crossbred Canine/dog | Ivermectin; Pyrantel As Pamoate Salt | Lack of efficacy (endoparasite) - heartworm | Outcome Unknown |
| Oct 3, 2025 | Dog | Spaniel - King Charles Cava... | Oclacitinib Maleate | Lack of efficacy - NOS | Ongoing |
| Oct 3, 2025 | Dog | Shih Tzu | Pyrantel Pamoate;Sarolaner | Hyperactivity; Panting; Discomfort NOS; Fever | Ongoing |
| Oct 3, 2025 | Dog | Basenji | Bedinvetmab | Unable to walk; General illness; Gait abnormality; Polydipsia; Ataxia; Knuckl... | Ongoing |
| Oct 3, 2025 | Dog | Poodle (unspecified), Dog (... | Oclacitinib Maleate | Lack of efficacy - NOS | Ongoing |
| Oct 3, 2025 | Dog | Coonhound (unspecified) | Ilunocitinib | Lack of efficacy - NOS; Urinary tract infection; Female reproductive tract di... | Outcome Unknown |
| Oct 3, 2025 | Dog | Beagle | Ilunocitinib | Diarrhoea; Lethargy (see also Central nervous system depression in Neurologic... | Ongoing |
| Oct 3, 2025 | Cat | Domestic Shorthair | Bexagliflozin | Elevated fructosamine; Elevated betahydroxybutyrate (BHP); Weight loss | Outcome Unknown |
| Oct 3, 2025 | — | Unknown | Imidacloprid; Moxidectin | Solution, Abnormal; Product defect, product difficult to use/handle (see also... | — |
| Oct 3, 2025 | Dog | Retriever - Labrador, Siber... | Oclacitinib Maleate | Soft stool; Emesis (multiple); Anorexia; Medication error NOS; Partial lack o... | Ongoing |
| Oct 3, 2025 | Cat | Ragdoll | Robenacoxib | Injection site mass NOS; Injection site swelling | Ongoing |
| Oct 3, 2025 | Dog | Basenji | Pimobendan | Unable to walk; General illness; Gait abnormality; Polydipsia; Ataxia; Knuckl... | Outcome Unknown |
| Oct 3, 2025 | Cat | Domestic Shorthair | Velagliflozin Proline Monohydrate | Ketosis | Outcome Unknown |
| Oct 3, 2025 | Dog | Beagle, Dog (unknown) | Lotilaner,Moxidectin,Praziquantel,Pyr... | Vomiting | Recovered/Normal |
| Oct 3, 2025 | Dog | Bulldog - English | Genta/Posacon/Mometa Eardrops | Application site pain; Application site discharge NOS; Application site infla... | Ongoing |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe — difficulty breathing, seizures, collapse, or severe swelling — seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.